The ReProgram

NAD and Aging: Did We Get the Story Wrong

ReProgram Episode 14 The NAD Myth? What the New Human Data Really Say🧠 Episode Overview In this episode of The ReProgram, Dr. George Murphy takes a critical but balanced look at one of the most popular ideas in the longevity space:That NAD levels decline with age — and that boosting NAD may help slow aging.But new human data challenge one of the most common assumptions behind the NAD story:Whole-blood NAD levels may not decline with age.This episode explores what that finding means — and what it does not mean.The central takeaway:NAD is not dead.But the simplistic NAD longevity story needs a reset. 🔑 Keywords NAD, NAD+, aging, longevity, NR, NMN, NAD boosters, nicotinamide riboside, nicotinamide mononucleotide, mitochondrial function, DNA repair, sirtuins, PARPs, CD38, cellular metabolism, biological aging, healthspan, resilience, recovery capacity, inflammation, stress response, biomarker, whole-blood NAD, NAD decline, NAD supplements, NAD IV therapy, metabolism, cellular stress, anti-aging supplements, longevity science, The ReProgram Podcast 🧠 Takeaways • NAD is essential biology, but it should not be treated as a magic anti-aging molecule. • New human data challenge the idea that whole-blood NAD levels universally decline with age. • Raising blood NAD is not the same thing as proving that aging has slowed. • NAD biology is likely tissue-specific, disease-specific, stress-specific, and context-dependent. • Blood NAD is not necessarily a reliable window into NAD metabolism in muscle, brain, liver, immune cells, or other tissues. • NAD boosters like NR and NMN can raise NAD-related metabolites, but that does not automatically mean they improve healthspan or longevity. • The most honest current framing is that NAD boosters are biologically plausible, biomarker-active, and clinically unproven as general longevity therapies. • NAD may be more relevant in specific contexts of stress, disease, frailty, metabolic dysfunction, or impaired recovery than as a universal supplement for healthy people. • NAD infusions and high-cost wellness protocols deserve extra skepticism because the marketing often exceeds the evidence. • Longevity interventions should be judged by function, resilience, healthspan, and clinical outcomes — not by biomarker movement alone. 🎙️ The ReProgram PerspectiveNAD biology matters, but the public story has become too simple.The key question is not whether we can raise NAD. The key question is whether doing so improves function, resilience, recovery, disease risk, or healthspan.Blood biomarkers can be useful, but they are not outcomes. Aging biology is not a supplement slogan.The ReProgram lens is clear: mechanism over marketing, outcome data over anecdotes, and trade-offs over hype. Chapters 00:00 The NAD Longevity Story Just Changed 01:24 What NAD Is and Why It Matters 03:31 NAD as Cellular Currency 04:37 The Old Model: Aging, Inflammation, and NAD Decline 06:32 The New Human Data on Whole-Blood NAD 08:30 Why Blood NAD Is Not the Whole Story 11:01 NAD Boosters: What They May Actually Do 12:58 NAD Boosters remain Scientifically Interesting 14:39 NAD Boosters: Limitations 16:55 Should You Take NAD for Longevity? 19:28 The ReProgram Takeaway: NAD Is Not Dead, But the Hype Needs a Reset Notes: Nature Metabolism Paper: Human whole-blood NAD+ levels do not vary with age or lifestyle interventions: https://www.nature.com/articles/s42255-026-01537-5 Cell Metabolism Paper: NAD depletion in skeletal muscle does not compromise muscle function or accelerate aging: https://www.cell.com/cell-metabolism/fulltext/S1550-4131(25)00212-8

Measuring and Modifying Biological Age: What the Science Actually Shows

ReProgram Episode 13 🧠 Episode Overview What does it actually mean to measure your biological age—and can it be changed? In this episode of The ReProgram, Dr. George Murphy sits down with Dr. Jesse Poganik, a leading scientist in the field of biological aging clocks and biomarkers of aging. Together, they unpack the science behind biological age—how it’s measured, what it reflects, and whether it represents a causal driver of aging or simply a readout of deeper biological processes. This conversation goes beyond the hype. It explores the emerging tools used to quantify aging, the limitations of current approaches, and what it will take to translate these measurements into meaningful clinical interventions. From organ transplantation to immune system signaling, Dr. Poganik shares how real-world biological systems are helping decode the mechanisms that shape how we age. 🔑 Keywords biological age, epigenetic clocks, aging biomarkers, DNA methylation, longevity science, healthspan, resilience, systems biology, immune aging, biomarkers of aging, translational medicine, aging mechanisms, clinical biomarkers, longevity interventions 🔬 What You’ll Learn • What “biological age” actually measures—and what it doesn’t • How epigenetic clocks are built and why they’ve gained traction • The difference between correlation and causation in aging biomarkers • Why systemic signals (like blood and immune factors) may regulate aging • How organ transplantation provides a natural experiment in aging biology • The biggest challenges in bringing biological age testing into the clinic • What standardization efforts (like the Biomarkers of Aging Consortium) aim to solve • Whether modifying biological age is currently possible—and what’s coming next 🎙️ The ReProgram Perspective Biological age is not just a number to optimize.It is a signal—one that reflects deeper biological processes we are only beginning to understand.The challenge is not simply to measure aging more precisely. The challenge is to determine whether those measurements represent something we can actually change.Because longevity is not about chasing metrics.It is about understanding the biology those metrics reflect and ultimately, learning how to influence it. 🎧 Final Thought We can now measure aging with increasing precision.But the real question remains: Are we measuring something we can change—or something we still don’t fully understand? Office Artifact: On the desk: Steampunk Pocket Watch Chapters00:00:00 Introduction to Measuring and Modifying Biological Age 00:04:07 Defining Biological Age 00:04:03 Epigenetic Clocks and Their Role in the Evolution of the Field 00:10:02 Causality in Aging Biomarkers 00:12:47 Clinical Applications of Biological Age 00:16:08 Nutritional Interventions and Biological Age 00:19:00 Understanding Aging Signatures 00:21:35 Transient Changes in Biological Age 00:24:27 Heterochronic Transplantation Studies 00:27:26 Blood as the Conduit of Aging or Rejuvenation Factors 00:30:25 Longitudinal Data in Organ Transplantation 00:33:23 The Biomarkers of Aging Consortium 00:36:25 The Birth of the Biomarkers of Aging Consortium 00:40:06 Personal Reflections on Aging and Longevity 00:41:47 Wrap Up and Putting It All Together Notes: Jesse Poganik, PhD: https://www.poganik.com/ Biomarkers of Aging Consortium: https://www.agingconsortium.org/ The inaugural collaborative manuscript of the Biomarkers of Aging Consortium was published in Cell: https://www.cell.com/cell/fulltext/S0092-8674(23)00857-7 Landmark Horvath Biological Age Paper: https://pubmed.ncbi.nlm.nih.gov/24138928/ Clinical Trials Using Biomarkers of Aging: CALERIE: https://clinicaltrials.gov/study/NCT00427193 DO-HEALTH: https://do-health.eu/about/trial/ COSMOS Multivitamin Trial: https://cosmostrial.org/

The Biology of Recovery: Why Adaptation Fails in Modern Life

ReProgram Episode 12 Most people think they need to do more.Train harder. Push further. Add more stimulus.But what if the real problem isn’t effort…What if your body can no longer recover from what you’re already doing?In this episode of The ReProgram, Dr. George Murphy reframes aging, performance, and longevity through a different lens:Recovery capacity.Rather than viewing aging as simple decline, this episode explores a more fundamental idea:that aging is the progressive loss of dynamic resilience—your ability to recover from stress.Because adaptation doesn’t come from what you do.It comes from what your body can recover from.If you’re training hard but not progressing…If you’re doing more but getting less back…If fatigue is accumulating instead of resolving…The issue may not be effort.It may be recovery. This episode breaks down: • What recovery actually is (and why it’s not passive) • Why modern life disrupts recovery at a systems level • The biological relationship between stress, adaptation, and repair • Why increasing effort can sometimes accelerate decline • How to recognize when recovery—not stimulus—is the limiting factor • A new framework for thinking about aging, resilience, and long-term function This is not a conversation about doing less.It’s a conversation about aligning what you ask of your body with what it can actually recover from.Because ultimately, resilience is not defined by how much stress you can endure—It’s defined by how well you can recover. 🔑 Keywords recovery, resilience, aging, longevity, adaptation, stress, recovery capacity, overtraining, fatigue, burnout, performance plateau, healthspan, systems biology, metabolic health, sleep, training, exercise physiology, nervous system, hormesis, modern stress, biological resilience 🧠 Takeaways • Recovery is not passive—it is an active biological process that determines whether stress leads to adaptation or breakdown. • The body does not adapt to what we do; it adapts to what it can recover from. • Aging can be understood as the progressive loss of dynamic resilience—the ability to recover from disruption. • When recovery capacity declines, increasing effort often worsens outcomes rather than improving them. • Many modern stressors impair recovery by preventing full resolution of physiological strain. • Sustainable progress depends on aligning stimulus with recovery capacity, not maximizing input. 🎙️ The ReProgram Perspective Recovery is not the absence of effort.It is the biological process that makes effort meaningful.When recovery capacity is preserved, the body remains adaptable, responsive, and capable of maintaining function over time.But when that capacity declines, even the right inputs fail to produce the desired outcome.Longevity, therefore, is not simply about extending time—It is about preserving the ability to recover within that time. Office Artifact: On the desk: Funko Toys, Pop Movies Tron 489 Chapters 00:00:00 Understanding Recovery and Aging 00:01:35 Aging as Loss of Dynamic Resilience 00:04:03 The Importance of Recovery Capacity 00:06:28 A Personal Shift: From Training to Recovery 00:08:43 Why Modern Life Disrupts Recovery 00:11:18 Recognizing Signs of Under-Recovery 00:13:29 The Signals of Recovery and Adaptation 00:15:53 Strategies for Effective Recovery 00:18:12 Closing: Redefining Resilience

Muscle, Strength and The Biology of Staying Capable

In this episode of The ReProgram, Dr. George Murphy reframes skeletal muscle as far more than tissue for movement or aesthetics.Muscle is one of the body’s most powerful regulators of metabolic stability, resilience, recovery, and long-term functional independence.This conversation explores why the loss of muscle with age is not simply about weakness—it is a systems-level shift that affects glucose regulation, balance, neuromuscular coordination, recovery from stress, and ultimately how aging is experienced.Dr. Murphy breaks down the biology of sarcopenia, the profound role of resistance training across the lifespan, and why it is never too late to restore meaningful strength and function.The episode also challenges a common myth in aging:that we should reduce challenge as we get older.Instead, the real goal is intelligent, appropriately scaled resistance that preserves the biological signals required for adaptation.This is not a conversation about physique.It is a conversation about remaining capable.About preserving the systems that allow us to move through the world with confidence, recover from disruption, and maintain independence for as long as biology allows. 🔑Keywords muscle, skeletal muscle, strength, longevity, resistance training, sarcopenia, healthy aging, healthspan, neuromuscular aging, frailty, metabolism, glucose regulation, muscle loss, functional aging, independence, resilience, exercise science, late-life training, muscle physiology, healthy lifespan 🧠 Takeaways • Skeletal muscle is not cosmetic tissue—it is biological infrastructure for metabolism, recovery, and resilience. • Aging is experienced through loss of function, and muscle is one of the most modifiable systems that shapes that trajectory. • Resistance training remains effective across the lifespan, even when initiated later in life. • “Heavy” is relative to current capacity—the goal is intelligent challenge, not maximal load. • Strength reflects integrated systems biology, including muscle quality, neural coordination, and recovery capacity. • Longevity is ultimately about preserving capability, independence, and the ability to engage with life on your own terms. 🎙️ The ReProgram Perspective Muscle is not about aesthetics.It is the biological infrastructure of capability.When we challenge it intelligently, we are not chasing strength for its own sake—we are preserving the systems that allow us to remain independent within time. Office Artifact: On the desk: Handexer digital hand dynamometer: https://www.amazon.com/Handexer-Strengtheners-Dynamometer-Measurement-Electronic/dp/B0B1LNFSVB/ref=ast_sto_dp_puis?th=1 Chapters 00:00:00 The True Role of Muscle in Aging 00:02:26 Redefining Muscle Beyond Aesthetics 00:03:20 Muscle as a Metabolic Regulator 00:05:19 Muscle Contributes to Longevity in Multiple Ways 00:07:24 Understanding Sarcopenia and its Implications 00:08:15 The Power of Resistance Training 00:12:18 Intensity and Resistance Training for Aging 00:16:22 The Neurological Aspect of Strength 00:21:41 Conclusion: Putting It All Together

Peptides for Longevity: What No One Tells You About Anti-Aging

In this episode—Part 3 of the Peptides 101 series—we move beyond healing and performance to examine one of the most compelling and misunderstood frontiers in modern medicine: longevity and anti-aging peptides.But this is where the conversation changes.Because using peptides to recover from injury is fundamentally different from using them to modify the trajectory of aging itself.In this episode, we break down the biology behind commonly discussed longevity peptides—including Epitalon, MOTS-c, and Thymosin Alpha-1—through the lens of signaling, systems biology, and long-term risk.We explore critical pathways like mTOR, telomere dynamics, mitochondrial signaling, and immune regulation, and examine the central tension that defines aging biology: 👉 The same signals that promote growth and repair early in life may accelerate disease later on.This episode is not about hype.It’s about mechanism, trade-offs, and the reality that biology does not offer intervention without consequence. 🔑Keywords peptides, anti-aging, longevity, mTOR, telomeres, mitochondria, cancer risk, regeneration, immune signaling, growth hormone, epitalon, MOTS-c, thymosin alpha-1, signaling, science, clinical trials, regenerative medicine, aging biology, healthspan 🧠 Takeaways • Peptides are not supplements—they are biological signals that influence complex systems. • Longevity interventions aim to alter trajectory, not just restore baseline.• Growth signaling pathways (GH, IGF-1, mTOR) create a fundamental trade-off between repair and long-term risk. • Aging is not driven by a single pathway—it reflects interconnected biological systems under constraint. Epitalon (Telomere Biology) • Proposed to activate telomerase and influence cellular aging. • Telomerase is tightly regulated for a reason—uncontrolled activation is a hallmark of cancer biology. • Long-term human outcome data remains limited. MOTS-c (Mitochondrial Signaling) • A mitochondrial-derived peptide involved in metabolic regulation and stress response. • Shows promise in improving metabolic flexibility in animal models. • Early-stage science—not yet proven to impact human longevity outcomes. Thymosin Alpha-1 (Immune Modulation) • Influences immune signaling and has established clinical use in specific conditions. • Aging applications must consider the balance between immune activation and dysregulation. • Immune systems are not simply “boosted”—they are finely regulated networks. • Longevity is measured in decades—not weeks or months.• Short-term biomarker improvements do not equal long-term outcome benefits. • Increasing growth and survival signaling later in life introduces biological uncertainty—particularly in cancer risk. • The absence of long-term human data is not a minor gap—it is the central limitation. 🎙️ The ReProgram Perspective Peptides are powerful because they are instructions.And when you introduce new instructions into a system shaped by evolution, you inherit the trade-offs that evolution never eliminated.Curiosity is essential.But discipline is what protects long-term health. Office Artifact: On the desk: Yipwon/Garra Figure, Sepik River hardwood, representing nature spirits or ancestral power, Papua New Guinea, 2019 Chapters 00:00:00 Introduction to Peptides and Longevity 00:00:51 Understanding Peptides as Signals 00:03:39 The Biological Paradox of Growth Signaling 00:05:08 mTOR and its Role in Aging Biology 00:11:07 Exploring Longevity peptides: Epitalon, MOTS-c, and Thymic Peptides 00:15:37 The Complexities of Growth Hormone Signaling 00:17:23 The Scientific Position on Longevity Peptides 00:21:10 Cancer Biology and Growth Signaling 00:24:28 Conclusion: The Importance of Discipline in Longevity Research